ELRIG Drug Discovery 2013
03 September 2013 - 04 September 2013
The 2013 programme will contain presentations from leading scientists across European Drug Discovery, covering innovations and advances in basic and translational aspects of drug discovery: covering topics such as Innovations in Assay Development, through Oncology Drug Discovery, Macromolecules, Safety & DMPK Screening, Sample Management, Stem Cells, and Stratified Medicine.
Each year, this conference provides a fantastic communication and learning opportunity for scientists engaged at the leading edge of drug discovery, whether in Academia, Biotech or Pharma. As with our highly successful meeting in 2012, attendees will hear world class speakers discussing the challenges and opportunities facing drug discovery scientists today. Drug Discovery ’13 will include a scientific poster session, networking sessions, and a large vendor exhibition.
Manchester Central Convention Complex, Petersfield, Manchester, M2 3GX, UK
http://www.elrig.org/
6th CNS Partnering and Deal Making Conference
09 September 2013 - 10 September 2013
Over the past years, this partnering and business development conference has given global biotechnology and pharmaceutical companies an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, as well as explore potential collaborations, and learn about relevant CNS disease issues that will affect the industry.
However, with the unmet need for CNS treatments growing, it is time to reevaluate how we partner with other stakeholders in the field to accelerate research. We will discuss research consortia, collaborations between academic centers and industry, and the growing role of patient groups and foundations. This meeting creates a space for leaders in the field to gather and invest in partnerships that will accelerate research and move the field forward.
Taj Boston, Boston MA, USA
http://www.gtcbio.com/conference/cns-partnering-and-deal-making-overview
43rd Annual Meeting of German Society for Immunology (DGfI) 2013
11 September 2013 - 14 September 2013
University of Mainz, Saarstraße 21, Mainz, Germany
http://www.dgfi.org/
4th Biobased Chemicals: Commercialization & Partnering Conference
16 September 2013 - 17 September 2013
The conference will look to examine new supply chain developments and business models being adopted for biobased chemicals products. Topics covered include novel chemical production platforms, advantageous feedstock, end user applications, securing funding and strategic partnerships and trends and challenges in commercial scale up. Renewable chemical companies, biofuel companies and end market consumers will be discussing innovations in the science, technology and end-market development of biobased chemicals, polymers and plastics. Get the latest updates from investment, scientific, manufacturer and business perspectives - the highlights and the challenges to making big new things happen with special emphasis on commercialization.
Hotel Kabuki, 1625 Post St., San Francisco, CA, 94115, USA
http://www.gtcinsight.com/conference/biobased-chemicals-commercialization-partnering-overview
Clinically Relevant Drug Transporters
16 September 2013 - 18 September 2013
Building on the success on IQPC’s 2012 conference, this year’s meeting takes unites basic, preclinical, translational and clinical research with numerous case studies. New for 2013 will be round-table sessions uniting business development with clinical progress. These will include time and money-saving approaches to meet filing requirements, and new requests from regulators based on known substrates for clinical interactions.
London, UK
http://www.drugtransporters.com/
Geriatric Safe Medicines Summit
16 September 2013 - 17 September 2013
Age demographics are shifting in both the developing and developed world. Higher standards of living, better health care and the implementation of welfare systems all contribute to increased longevity, but with an ever growing older population health burdens are shifting and the treatment of age related disease conditions is increasing. The challenges involved in the treatment of the older patient are numerous. Co-morbidities, lack of clinical trial data on the target population, challenges of drug-drug interactions, compliance and a number of ethical issues surrounding the treatment of the older population are all concerns of those working within geriatric medicine.
Join SMi for their inaugural Geriatric Safe Medicines Summit as they seek to address these issues and many more in what promises to be a highly thought provoking and stimulating event.
Marriott Hotel, Regents Park, London, UK
http://www.smi-online.co.uk/pharmaceuticals/uk/conference/Geriatric-Safe-Medicines-Summit?utm_source=P-113&utm_medium=EM%20-%202S&utm_campaign=GroupMail
Dotmatics European User Group Meeting
16 September 2013 - 17 September 2013
World renowned South African gourmet chef Chris van Niekerk will cater the two day FREE event at the historical Down Hall Country House Hotel which is located just a short distance from London, Cambridge and Stansted Airport. The English countryside setting provides the perfect framework in which to network with industry peers and share ideas on the interrogation and analysis of data via the Domatics Platform.
Confirmed speakers include leading scientists from Grünenthal, Thomson Reuters, Leo Pharma, Cancer Research Technology, the University of Newcastle and the University of Leeds amongst others.
Down Hall Country House Hotel, Hertfordshire, UK
http://www.dotmatics.com/dotmatics-european-user-group-meeting/
European Cancer Congress
27 September 2013 - 01 October 2013
The 17th ECCO – 38th ESMO – 32nd ESTRO European Cancer Congress is organised in partnership with ESSO 33, EACR, EONS and SIOPE. The European Cancer Congresses are consequently the only multidisciplinary and multi-professional educational opportunity in oncology to take place in Europe – a fact that underpins the relevance, role and participation of each and every speciality in oncology.
Thanks to this multidisciplinary collaboration, oncology professionals and patient advocates alike will be able to see and learn from the tangible benefits of cancer disciplines working together, with active patient involvement at the heart of discussions.
Amsterdam, Netherlands
http://www.esmo.org/Conferences/European-Cancer-Congress-2013
Drug Discovery India 2013
27 September 2013 - 28 September 2013
Pharmaceutical industry is utilizing a plethora of novel approaches, techniques and technologies for Drug Design and Discovery. Use of novel interdisciplinary approaches, developed by understanding integrated biological systems and processes at the functional and molecular levels, has made the discovery process more rational, but complex too. Therefore for optimizing the discovery and development of new molecular entities, it is a current practice to follow collaborative research amongst interdisciplinary academic/research centers, government agencies and pharmaceutical industry.
Dr. Rathnam Chaguturu (Senior Director, SRI International, USA) serving as the Conference Chair, Drug Discovery India 2013 will provide an excellent platform for researchers from all facets of drug discovery research to discuss the future perspectives and also an unprecedented opportunity to explore the contract research and collaborative options amongst various research fraternities. Planned open panel discussions and break-out sessions on key thematic areas are sure to energize the participants in defining the drug discovery and development landscape, especially within the Indian context, and offer ways and means to de-risk the patent cliff experienced by the pharmaceutical industry in recent years.
Bangalore, India
http://selectbiosciences.com/conferences/index.aspx?conf=DDI2013
13th Annual Biotech in Europe Investor Forum
30 September 2013 - 01 October 2013
The forum is recognised as the leading international stage for those interested in investing in the biotech and life science industry and is highly transactional, drawing together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharmas. Supported and designed by leading figures within Europe’s bio industry, this event will once again be covered by our regular media partners. We expect around 350 delegates and 80 presenting companies.
Hilton Zurich Airport Hotel, Zurich, Switzerland
http://www.sandtiger.co.uk/zurich13/registration-enquiry.php